This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

Dexcom's CGM systems include sensors for placement on the back of the arm or lower abdomen. They also include the option of ...

Every study in these AID systems has been done with the DexCom sensor. So there aren't any head-to-head studies. They've all been run with DexCom, at least with our pump partners, and that's the ...

While there is some optimism around Dexcom’s efforts to rebuild the Durable Medical Equipment (DME) channel and the filing of the 15-day G-Series sensor with the FDA, the softer US performance ...

Apple has been bulking up the Watch’s health offerings too, though. Aside from having compatibility with Dexcom sensors since its launch in 2015, the firm is experimenting with its own CGM add ...

DexCom (DXCM) reported $994.2 million in revenue ... The reported number represents a year-over-year change of -58.1%. Revenue- Sensor and other: $951.80 million versus the two-analyst average ...

Oppenheimer analyst Steven Lichtman lowered the firm’s price target on DexCom (DXCM) to $105 from $115 and keeps an Outperform rating on ...

DexCom concluded the third quarter of 2024 on a positive note, with earnings and revenues surpassing expectations. Key drivers included significant contributions from the Sensor segment and robust ...

DexCom, Inc. DXCM reported third-quarter 2024 ... The broader S&P 500 index has moved up 21.6% in the same period. Sensor and other revenues (96% of total revenues) increased 9% on a year-over ...